Nurix therapeutics announces publication in the journal science identifying a new class of btk mutations that are susceptible to nx-2127, a novel btk and ikzf1/3 degrader

Data reveal oncogenic scaffold function of btk mutations that lack kinase activity and show these mutations remain susceptible to degradation by nx-2127

NRIX Ratings Summary

NRIX Quant Ranking